High-grade glioma in elderly patients: can the oncogeriatrician help?

References

• GreigNHRiesLGYancikRRapoportSIIncreasing annual incidence of primary malignant brain tumors in the elderlyJ Natl Cancer Inst199082162116242213902
   PubMed Web of Science ®Google Scholar
• ChakrabartiICockburnMCozenWWangYPPreston-MartinSA population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999Cancer20051042798280616288487
   PubMed Web of Science ®Google Scholar
• CurranWJJrScottCBHortonJRecursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsJ Natl Cancer Inst1993857047108478956
   PubMed Web of Science ®Google Scholar
• LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol20071149710917618441
   PubMed Web of Science ®Google Scholar
• CairncrossGWangMShawEPhase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402J Clin Oncol20123133734323071247
   PubMed Web of Science ®Google Scholar
• van den BentMJBrandesAATaphoornMJAdjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951J Clin Oncol20123134435023071237
   PubMed Web of Science ®Google Scholar
• ReifenbergerGHentschelBFelsbergJPredictive impact of MGMT promoter methylation in glioblastoma of the elderlyInt J Cancer20121311342135022139906
   PubMed Web of Science ®Google Scholar
• WickWPlattenMMeisnerCTemozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialLancet Oncol20091370771522578793
   PubMed Web of Science ®Google Scholar
• WiestlerBClausRHartliebSAMalignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveNeuro Oncol2013151017102623595628
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkComprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature20084551061106818772890
   PubMed Web of Science ®Google Scholar
• NghiemphuPLLiuWLeeYBevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experienceNeurology2009721217122219349600
   PubMed Web of Science ®Google Scholar
• SanaJHajduchMMichalekJVyzulaRSlabyOMicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implicationsJ Cell Mol Med2011151636164421435175
   PubMed Web of Science ®Google Scholar
• RicardDIdbaihADucrayFLahutteMHoang-XuanKDelattreJYPrimary brain tumours in adultsLancet20123791984199622510398
   PubMed Web of Science ®Google Scholar
• DeorahSLynchCFSibenallerZARykenTCTrends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001Neurosurg Focus200620E116709014
   PubMedGoogle Scholar
• LowryJKSnyderJJLowryPWBrain tumors in the elderly: recent trends in a Minnesota cohort studyArch Neurol1998559229289678309
   PubMedGoogle Scholar
• BurkhardtKHeubergerFDelavelleJPilocytic astrocytoma in the elderlyClin Neuropathol20072630631018232598
   PubMed Web of Science ®Google Scholar
• BensonVSPirieKSchüzJReevesGKBeralVGreenJMobile phone use and risk of brain neoplasms and other cancers: prospective studyInt J Epidemiol20134279280223657200
   PubMed Web of Science ®Google Scholar
• IwamotoFMCooperARReinerASNayakLAbreyLEGlioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997–2007)Cancer20091153758376619484785
   PubMed Web of Science ®Google Scholar
• DhermainFGHauPLanfermannHJacobsAHvan den BentMJAdvanced MRI and PET imaging for assessment of treatment response in patients with gliomasLancet Neurol2010990692020705518
   PubMed Web of Science ®Google Scholar
• WenPYMacdonaldDRReardonDAUpdated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupJ Clin Oncol2010281963197220231676
   PubMed Web of Science ®Google Scholar
• IwamotoFMReinerASNayakLPanageasKSElkinEBAbreyLEPrognosis and patterns of care in elderly patients with gliomaCancer20091155534554019708033
   PubMed Web of Science ®Google Scholar
• LutterbachJBarteltSMommFBeckerGFrommholdHOstertagCIs older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastasesCancer20051031234124415666327
   PubMed Web of Science ®Google Scholar
• VillàSViñolasNVergerEEfficacy of radiotherapy for malignant gliomas in elderly patientsInt J Radiat Oncol Biol Phys1998429779809869218
   PubMed Web of Science ®Google Scholar
• TanakaSMeyerFBBucknerJCUhmJHYanESParneyIFPresentation, management, and outcome of newly diagnosed glioblastoma in elderly patientsJ Neurosurg201311878679823176331
   PubMed Web of Science ®Google Scholar
• IwamotoFMReinerASPanageasKSElkinEBAbreyLEPatterns of care in elderly glioblastoma patientsAnn Neurol20086462863419107984
   PubMed Web of Science ®Google Scholar
• FiorentinoACaivanoRChiumentoCComorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastomaMed Oncol2012293467347122580816
   PubMed Web of Science ®Google Scholar
• MohanDSSuhJHPhanJLKupelianPACohenBHBarnettGHOutcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institutionInt J Radiat Oncol Biol Phys1998429819879869219
   PubMed Web of Science ®Google Scholar
• GlantzMChamberlainMLiuQLitofskyNSRechtLDTemozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomasCancer2003972262226612712481
   PubMed Web of Science ®Google Scholar
• ScottJGBauchetLFraumTJRecursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderCancer20121185595560022517216
   PubMed Web of Science ®Google Scholar
• SimpsonJRHortonJScottCInfluence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trialsInt J Radiat Oncol Biol Phys1993262392448387988
   PubMed Web of Science ®Google Scholar
• MartinezRJankaMSoldnerFBehrRGross-total resection of malignant gliomas in elderly patients: implications in survivalZentralbl Neurochir20076817618117963194
   PubMedGoogle Scholar
• VuorinenVHinkkaSFärkkiläMJääskeläinenJDebulking or biopsy of malignant glioma in elderly people – a randomised studyActa Neurochir (Wien)200314551012545256
   PubMed Web of Science ®Google Scholar
• MeneiPMetellusPParot-SchinkelEBiodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experienceAnn Surg Oncol2010171740174620443147
   PubMed Web of Science ®Google Scholar
• WestphalMHiltDCBorteyEA phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant gliomaNeuro Oncol20035798812672279
   PubMed Web of Science ®Google Scholar
• Keime-GuibertFChinotOTaillandierLRadiotherapy for glioblastoma in the elderlyN Engl J Med20073561527153517429084
   PubMed Web of Science ®Google Scholar
• DonatoVMonacoARolloAElderly and poor prognosis patients with high grade glioma: hypofractionated radiotherapyClin Ter200715822723017612282
   PubMedGoogle Scholar
• HoeglerDBDaveyPA prospective study of short course radiotherapy in elderly patients with malignant gliomaJ Neurooncol1997332012049195491
   PubMed Web of Science ®Google Scholar
• RoaWBrasherPMBaumanGAbbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trialJ Clin Oncol2004221583158815051755
   PubMed Web of Science ®Google Scholar
• ChinotOLBarrieMFraugerEPhase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populationsCancer20041002208221415139066
   PubMed Web of Science ®Google Scholar
• Gállego Pérez-LarrayaJDucrayFChinotOTemozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trialJ Clin Oncol2011293050305521709196
   PubMed Web of Science ®Google Scholar
• MalmströmAGrønbergBHMarosiCTemozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialLancet Oncol20121391692622877848
   PubMed Web of Science ®Google Scholar
• BrandesAAVastolaFBassoUA prospective study on glioblastoma in the elderlyCancer20039765766212548608
   PubMed Web of Science ®Google Scholar
• SantoniMScocciantiSLolliIEfficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaJ Neurooncol201311339740123564276
   PubMed Web of Science ®Google Scholar
• ReithmeierTGrafEPirothTTrippelMPinskerMONikkhahGBCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factorsBMC Cancer2010103020122270
   PubMed Web of Science ®Google Scholar
• GrantRLiangBCPageMACraneDLGreenbergHSJunckLAge influences chemotherapy response in astrocytomasNeurology1995459299337746409
   PubMed Web of Science ®Google Scholar
• StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med200535298799615758009
   PubMed Web of Science ®Google Scholar
• FiorentinoABalducciMDe BonisPCan elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?Am J Clin Oncol Epub252013
   Web of Science ®Google Scholar
• MinnitiGScaringiCBaldoniAHealth-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomideInt J Radiat Oncol Biol Phys20138628529123642624
   PubMed Web of Science ®Google Scholar
• KreislTNKimLMooreKPhase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaJ Clin Oncol20092774074519114704
   PubMed Web of Science ®Google Scholar
• TabouretEBarrieMThiebautALimited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimenJ Neurooncol201311419119823756726
   PubMed Web of Science ®Google Scholar
• AhnGOBrownJMRole of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculatureAngiogenesis20091215916419221886
   PubMed Web of Science ®Google Scholar
• ThomasTPThe complications of systemic corticosteroid therapy in the elderly. A retrospective studyGerontology19843060656698408
   PubMed Web of Science ®Google Scholar
• KerkhofMDielemansJCvan BreemenMSEffect of valproic acid on seizure control and on survival in patients with glioblastoma multiformeNeuro Oncol20131596196723680820
   PubMed Web of Science ®Google Scholar
• KarnofskyDAChemotherapy of neoplastic disease; agents of clinical valueN Engl J Med194823929930518875995
   PubMed Web of Science ®Google Scholar
• DouwLKleinMFagelSSCognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-upLancet Neurol2009881081819665931
   PubMed Web of Science ®Google Scholar
• AudisioRAGennariRSunouchiKPreoperative assessment of cancer in elderly patients: a pilot studySupport Cancer Ther20031556018628132
   PubMedGoogle Scholar
• RameshHSBoaseTAudisioRARisk assessment for cancer surgery in elderly patientsClin Interv Aging2006122122718046874
   PubMed Web of Science ®Google Scholar
• CecileMSeuxVPaulyVAdverse drug events in hospitalized elderly patients in a geriatric medicine unit: study of prevalence and risk factorsRev Med Interne200930393400 French19349098
   PubMed Web of Science ®Google Scholar
• HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med2005352997100315758010
   PubMed Web of Science ®Google Scholar
• MinnitiGLanzettaGScaringiCPhase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastomaInt J Radiat Oncol Biol Phys201283939922079725
   PubMed Web of Science ®Google Scholar
• MinnitiGDe SanctisVMuniRHypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastomaJ Neurooncol2009919510018758912
   PubMed Web of Science ®Google Scholar
• MinnitiGDe SanctisVMuniRRadiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patientsJ Neurooncol2008889710318250965
   PubMed Web of Science ®Google Scholar
• CombsSEWagnerJBischofMPostoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patientsInt J Radiat Oncol Biol Phys20087098799217967509
   PubMed Web of Science ®Google Scholar
• SijbenAEMcIntyreJBRoldanGBToxicity from chemoradiotherapy in older patients with glioblastoma multiformeJ Neurooncol2008899710318398569
   PubMed Web of Science ®Google Scholar
• LeeJHJungTYJungSPerformance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiformeJ Clin Neurosci20132050350823313530
   PubMed Web of Science ®Google Scholar
• FloydSRKasperEMUhlmannEJFonkemEWongETMahadevanAHypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients – early results of a Phase II trialFront Oncol2012212223087896
   PubMedGoogle Scholar